Combined therapy comprising nemorubicin and a...

Details Combined therapy comprising nemorubicin and a... Combined therapy comprising nemorubicin and a...

A - Human Necessities

61

K

A61K 31/704 (2006.01)

Patent

CA 2519310

The present Invention relates to the use of a morpholinyl anthracycline derivative, a pharmaceutically acceptable salt or a metabolite thereof, for the preparation of a medicament In combination with a Cox-2 Inhibitor for simultaneous, separate or sequential use for the treatment of cancer and to compositions or packaged units comprising a morpholinyl anthracycline derivative and a Cox-2 Inhibitor.

La présente invention concerne l'utilisation d'un dérivé d'anthracycline de morpholinyle, d'un sel pharmaceutiquement acceptable ou d'un métabolite dudit dérivé, aux fins de la préparation d'un médicament associé à un inhibiteur de Cox-2, pour une utilisation simultanée, séparée ou séquentielle dans le traitement du cancer. Elle concerne également des compositions ou des unités posologiques conditionnées contenant un dérivé d'anthracycline de morpholinyle et un inhibiteur de Cox-2.

Affiliated with

Also associated with

Rating

Combined therapy comprising nemorubicin and a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combined therapy comprising nemorubicin and a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined therapy comprising nemorubicin and a... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1858174